Bryan Vander Lugt
Amgen (United States)(US)Inflammation Research Foundation(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Cell Function and Interaction, Immune Response and Inflammation, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation(2013)390 cited
- → A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1–IRF Complexes(2012)348 cited
- → Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation(2013)243 cited
- → Transcriptional determinants of tolerogenic and immunogenic states during dendritic cell maturation(2017)83 cited
- → CCR7 Plays No Appreciable Role in Trafficking of Central Memory CD4 T Cells to Lymph Nodes(2013)34 cited
- → TGF-β Suppresses β-Catenin-Dependent Tolerogenic Activation Program in Dendritic Cells(2011)24 cited
- → The Molecular Choreography of IRF4 and IRF8 with Immune System Partners(2013)20 cited
- → Quantitative measurement of the requirement of diverse protein degradation pathways in MHC class I peptide presentation(2023)13 cited
- → Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions(2023)12 cited
- → Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control(2023)8 cited